Bio-Me has announced that Heiner Dreissman and Charles Stabell have been appointed as senior advisors.
These steps are part of the company’s strategic plan to position Bio-Me as a leader in the field with its Precision Microbiome Profiling (PMP) platform which offers a targeted approach to microbiome analysis/profiling using state-of-the-art qPCR and are in advance of a new funding round, it states.
“As we expand our range of clinical applications and enter a major growth phase, we are delighted to bring Dr. Heiner and Dr. Stabell on board. Their vast experience will prove invaluable as we look to establish a sustainable leadership position in the exciting field of precision microbiome medicine,” says Warren Flood, CEO, Bio-Me.
Heiner Dreissman
As an international executive, Dr. Heiner Dreismann brings more than 35 years of experience from biotech and healthcare companies, with a proven track record in general management with P&L responsibilities and management of corporate functions such as R&D, manufacturing, marketing, and business development. During his 25+ years in Roche’s diagnostic division, he also managed licensing and M&A opportunities. He is the former President and CEO of Roche Molecular Systems, a world leader in Molecular Diagnostics. Heiner has served on the boards of several public and private companies. He holds a PhD in Microbiology/Molecular Biology from Westphalian Wilhelms University, Münster.
“I am confident that the microbiome will play a major role in future clinical care, and that properties of the Precision Microbiome Profiling (PMP) solution overcome many of the limitations of competing technologies in clinical practice. Bio-Me is well positioned to be a key player in the clinical microbiome diagnostics space,” says Dreismann.
Charles Stabell
Dr. Charles Stabell has a long track record in academia and as an entrepreneur and is now an active high-tech investor and advisor. He was one of the co-founders and the CEO of GeoKnowledge, a firm that developed the de facto global standard tools for stochastic prospect assessment modeling in exploration opportunities in the petroleum industry. The company was acquired by Schlumberger in 2012. He was for 25 years in teaching and research, most recently as a professor in business strategy at the Norwegian School of Management (BI); earlier amongst other as an assistant professor in computers and information systems at the Graduate School of Business, Stanford University. Charles is an electronics engineer from ENSERG (Grenoble, France), has an MBA from McGill University (Montreal), and a PhD from the Sloan School of Management, Massachusetts Institute of Technology (MIT).
“Data generated from microbiome profiling with Precision Microbiome Profiling (PMPTM) can be effectively used to create novel prediction models for health and disease that can be utilized both clinically and in preventive health applications. I look forward to supporting Bio-Me in making good strategic moves in an exciting space,” says Stabell.
Photo: iStock
